1. Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder
2. U.S.
Food and Drug Administration. Final Monograph for OTC Nasal Decongestant Drug
Products Federal Register, 1994, Vol. 59. https://www.govinfo.gov/content/pkg/FR-1994-08-23/html/94-20456.htm.
3. U.S. Food and Drug Administration. Partial Stay of Effective Date: l-desoxyephedrine Federal Register, 1996, Vol. 61, pp 9569–9570. https://www.govinfo.gov/content/pkg/FR-1996-03-08/html/96-5444.htm.
4. U.S. Food and Drug Administration. Final Rule: Adds and renames l-desoxyephedrine
to
levmetamphetamine. Federal Register, 1998, Vol. 63, pp 40647–40650. https://www.govinfo.gov/content/pkg/FR-1998-07-30/pdf/98-20303.pdf.
5. U.S. Food and Drug Administration. Vicks VapoInhaler-levmetamfetamine
inhalant: The
Procter & Gamble Manufacturing Company. https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=225458 (accessed 01/30/2023).